Dr Sarah Wamala Andersson | Consultant, Real World Evidence and Value-based medicines
Independent

Sarah Wamala Andersson has recently served as the Principal Research Scientist (real world evidence) for the Northern European Cluster at Eli Lilly & Company. Sarah has previously worked as a Professor of Health Policy and Karolinska Institutet, Director General (CEO) of the Swedish National Institute of Public Health (reporting to the Minister of Health and Social Affairs), and as a Director at the Stockholm County Council. Sarah is trained in four continents. Sarah holds a PhD in Medical Sciences, a Master's degree in Biostatistics, a Bachelor's Degree in Economics and a diploma in Business Administration.